Macropinocytosis in KRAS-Mutant Cancers: Biological Functions and Therapeutic Opportunities in Pancreatic Ductal Adenocarcinoma
Oncogenic mutations in KRAS are primary drivers of human malignancies, particularly in pancreatic, colorectal, and lung adenocarcinomas. Although allele-selective inhibitors have shown clinical activity in some settings, their applicability varies by KRAS allele and tumor type. An important metabolic adaptation observe...